Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
Positive results from Winston Laboratories' Civamide Patch trial

Positive results from Winston Laboratories' Civamide Patch trial

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Endo Pharmaceuticals reaches patent litigation settlement with LecTec

Endo Pharmaceuticals reaches patent litigation settlement with LecTec

EpiCept announces third quarter 2009 financial results

EpiCept announces third quarter 2009 financial results

Third-quarter 2009 financial results announced by Inhibitex

Third-quarter 2009 financial results announced by Inhibitex

American Shared Hospital Services reports financial results for the third quarter of 2009

American Shared Hospital Services reports financial results for the third quarter of 2009

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Update from Endo Pharmaceuticals regarding its New Drug Application for FORTESTA

Update from Endo Pharmaceuticals regarding its New Drug Application for FORTESTA

Cobroxin OTC pain reliever is now available online

Cobroxin OTC pain reliever is now available online

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia

Nutra Pharma manufactures first commercial batch of Cobroxin

Nutra Pharma manufactures first commercial batch of Cobroxin

New drug combination releives neuropathic pain and improves sleep

New drug combination releives neuropathic pain and improves sleep

Drug registration process for Nutra Pharma's pain reliever begins

Drug registration process for Nutra Pharma's pain reliever begins

Millennium's sNDA for VELCADE granted priority review by the FDA

Millennium's sNDA for VELCADE granted priority review by the FDA

Results from Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 announced

Results from Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 announced

FDA approves Supplemental New Drug Application for DOXIL

FDA approves Supplemental New Drug Application for DOXIL

Banner Good Samaritan treats cancers and neurological disorders with the Novalis Tx radiosurgery platform

Banner Good Samaritan treats cancers and neurological disorders with the Novalis Tx radiosurgery platform

Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors

Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.